High Risk of Diabetes and Neurobehavioral Deficits in Individuals With Surgically Treated Hyperinsulinism

Katherine Lord1, Jerilynn Radcliffe1, Paul R Gallagher1

  • 1Division of Endocrinology and Diabetes (K.L., C.A.S., D.D.D.L.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; Department of Pediatrics (K.L., J.R., C.A.S., D.D.D.L.), The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104; Biostatistics Core (P.R.G.), The Clinical and Translational Research Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; and Department of Surgery (N.S.A.), The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104.

Insights

Children undergoing pancreatectomy for congenital hyperinsulinism (HI) face high risks of diabetes and neurobehavioral deficits. Early developmental assessments are crucial for managing these long-term complications in HI patients.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Surgical Outcomes

Background:

  • Congenital hyperinsulinism (HI) often necessitates pancreatectomy in severe cases to manage hypoglycemia.
  • Pancreatectomy increases diabetes risk, while persistent hypoglycemia can lead to neurocognitive dysfunction.
  • The long-term prevalence of these complications following surgical treatment for HI is not well-defined.

Purpose of the Study:

  • To determine the prevalence of diabetes and neurobehavioral deficits in individuals who underwent pancreatectomy for congenital hyperinsulinism (HI).

Main Methods:

  • A cross-sectional study design was employed, analyzing data from 121 subjects who had pancreatectomy for HI between 1960 and 2008.
  • Diabetes outcomes were assessed via patient interviews and medical records.
  • Neurobehavioral outcomes were evaluated using the Adaptive Behavior Assessment System, 2nd edition (ABAS-II) and the Child Behavior Checklist (CBCL).

Main Results:

  • 36% of subjects developed diabetes, with a higher proportion of pancreatectomy in those with diabetes (95%) compared to those without (65%).
  • Neurobehavioral abnormalities were reported in 48% of subjects, including abnormal scores on the ABAS-II (28%) and CBCL (16%).
  • Diabetes onset varied, with some diagnosed immediately post-surgery and others later in childhood or adolescence.

Conclusions:

  • Near-total pancreatectomy for congenital hyperinsulinism (HI) places children at significant risk for developing diabetes.
  • Neurobehavioral deficits are common sequelae in surgically treated HI patients.
  • Routine developmental and behavioral assessments are essential for comprehensive care of children with HI.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K